Matching slides 78,138
Current window 60,301-60,330
Pages 2,605
Rows per page 30
Component: Chartclear collectionreset all

Component

60,301-60,330 of 78,138

filter-aware
25
Includes detailed footnotes explaining the sources of funding and regulatory mandates.Proterra | Investor Presentation Deck | 28 slides · Proterra
Pitch deck Investor relations 1 hit
09
Includes a disclaimer regarding non-GAAP measures and illustrative assumptions.Rent The Runway | Results Presentation Deck | 28 slides · Rent The Runway
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
10
The chart distinguishes between active and paused subscribers, with paused subscribers represented by dashed-line segments.Rent The Runway | Results Presentation Deck | 28 slides · Rent The Runway
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
11
The chart compares quarterly revenue for FY20-FY22 against annual revenue for FY19-FY21 and FY22 guidance.Rent The Runway | Results Presentation Deck | 28 slides · Rent The Runway
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
12
The slide highlights a strategic shift to reduce upfront costs per unit by moving away from wholesale.Rent The Runway | Results Presentation Deck | 28 slides · Rent The Runway
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
13
The chart uses a waterfall-style logic to show how revenue per order is reduced by various expenses to arrive at net order economics.Rent The Runway | Results Presentation Deck | 28 slides · Rent The Runway
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
16
The chart illustrates how revenue growth and cost management (or lack thereof) impacted the margin bridge.Rent The Runway | Results Presentation Deck | 28 slides · Rent The Runway
Conference presentation Investor relations Beat · ActionLoop · Before After1 hit
19
The chart uses a split-axis approach to visualize positive and negative margin trends.Rent The Runway | Results Presentation Deck | 28 slides · Rent The Runway
Conference presentation Investor relations 1 hit
20
The slide uses a combination of a data table and a stacked bar chart to illustrate the reduction in product costs relative to revenue.Rent The Runway | Results Presentation Deck | 28 slides · Rent The Runway
Conference presentation Investor relations 1 hit
04
Reservoir | Investor Presentation Deck | 35 slidesReservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations 1 hit
07
The slide uses a multi-layered timeline approach to correlate strategic milestones with revenue growth.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations 1 hit
15
The slide uses a table-like structure to list initiatives and a bubble chart to compare growth rates.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
24
The chart shows a 31% CAGR for revenue over the 3-year period.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations Beat · Financials1 hit
26
Reservoir | Investor Presentation Deck | 35 slidesReservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations Beat · Financials1 hit
27
Includes assumptions regarding annual reinvestment strategy.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations Beat · Financials1 hit
09
The chart shows mean percent change from baseline with standard deviation bars.Roivant Sciences | Investor Presentation Deck | 21 slides · Immunovant
Pitch deck Investor relations 1 hit
20
The slide uses a color-coded legend to distinguish between trial initiation and data results for two different drug programs.Roivant Sciences | Investor Presentation Deck | 21 slides · Immunovant
Pitch deck Investor relations 1 hit
10
The chart shows a clear separation between the treatment and placebo groups, indicating faster viral clearance in the treatment arm.SAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
08
The chart is a classic waterfall plot used in oncology clinical trials to demonstrate efficacy.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
09
Waterfall plot showing individual patient responses; includes specific clinical trial metrics (ORR, PFS, OS).TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
10
Includes longitudinal CT scan imagery and a line chart tracking tumor diameter and volume reduction.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
11
Waterfall plot shows individual patient responses; ORR, PFS, and OS metrics provided.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
12
The slide uses a central human anatomy diagram to map specific cancer types to their respective mesothelin expression rates.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
18
Waterfall plot is a standard clinical trial visualization for tumor response.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
19
The chart uses a swimmer plot format to track longitudinal patient data including lymphodepletion status, response type, and survival.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
22
Includes longitudinal CT scan imagery and a line chart tracking tumor diameter and volume reduction over time.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
27
The chart displays individual patient responses, with multiple patients achieving significant tumor regression.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
30
The chart shows the breakdown of patient eligibility by MSLN expression levels (50%, 2+/3+ vs 50%, 1+ vs Not eligible).TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
31
The chart is a swimmer plot showing patient response over time, including redosing events and disease progression.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
33
The chart uses horizontal bars to represent the development stage of each program.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit